Document is current
Any future updates will be listed below
-
Authors
Wang, Zixuan https://orcid.org/0009-0002-6554-1230
He, Xuan https://orcid.org/0009-0004-4589-675X
Zhang, Xiaoyun https://orcid.org/0000-0002-4132-3573
Spiegel, Jochen https://orcid.org/0000-0001-7641-1066
Flynn, Sean M.
Balasubramanian, Shankar https://orcid.org/0000-0002-0281-5815
-
Funding
Funding for this research was provided by:
Cancer Research UK (SEBINT-2024/100003)
Cancer Research UK (C9681/A29214)
Wellcome Trust (209441/Z/17/Z)
- License Information
-
More Information
Article History
Received: 20 June 2025
Accepted: 19 February 2026
First Online: 19 March 2026
Competing interests
: S.B. is a founder and shareholder of biomodal, GenomeTx and RNAvate. J.S. is an employee of GenomeTx. The other authors declare no competing interests.
